Cargando…
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
Staphylococcus aureus infections associated with implanted medical devices are difficult to treat and require long-lasting antibiotic therapies, especially when device removal is not possible or easy such as in the case of joint prostheses. Biofilm formation is a major cause of treatment failure and...
Autores principales: | Gidari, Anna, Sabbatini, Samuele, Schiaroli, Elisabetta, Perito, Stefano, Francisci, Daniela, Baldelli, Franco, Monari, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484889/ https://www.ncbi.nlm.nih.gov/pubmed/32983061 http://dx.doi.org/10.3389/fmicb.2020.02085 |
Ejemplares similares
-
Fitness of Spontaneous Rifampicin-Resistant Staphylococcus aureus Isolates in a Biofilm Environment
por: Maudsdotter, Lisa, et al.
Publicado: (2019) -
Rifampicin-Manuka Honey Combinations Are Superior to Other Antibiotic-Manuka Honey Combinations in Eradicating Staphylococcus aureus Biofilms
por: Liu, Michael Y., et al.
Publicado: (2018) -
In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus
por: Jacob, Benjamin, et al.
Publicado: (2021) -
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2
por: Gidari, Anna, et al.
Publicado: (2022) -
Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022)